Skip to main content

Nasonex News

FDA Approves Nasonex 24HR Allergy (mometasone furoate) Nasal Spray for OTC Use

DUBLIN, March 17, 2022 /PRNewswire/ – Perrigo Company plc (NYSE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it has received final approval from the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Nasal Polyps, Hay Fever, Allergic Rhinitis

Nasonex patient information at Drugs.com